OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem

References

• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228–236.
   PubMed Web of Science ®Google Scholar
• Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:2723–2725.
   PubMed Web of Science ®Google Scholar
• Weisenberg SA, Morgan DJ, Espinal-Witter R, Larone DH. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem. Diagn Microbiol Infect Dis 2009;64:233–235.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob Agents Chemother 1993;37:939–946.
   PubMed Web of Science ®Google Scholar
• Naas T, Vandel L, Sougakoff W, Livermore DM, Nordmann P. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob Agents Chemother 1994;38:1262–1270.
   PubMed Web of Science ®Google Scholar
• Yigit H, Queenan AM, Rasheed JK, Biddle JW, Domenech-Sanchez A, Alberti S et al. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2. Antimicrob Agents Chemother 2003;47:3881–3889.
   PubMed Web of Science ®Google Scholar
• Fritsche TR, Sader HS, Toleman MA, Walsh TR, Jones RN. Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program. Clin Infect Dis 2005;41 Suppl 4:S276–S278.
   PubMed Web of Science ®Google Scholar
• Evans BA, Hamouda A, Towner KJ, Amyes SG. OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin Microbiol Infect 2008;14:268–275.
   PubMed Web of Science ®Google Scholar
• Vahaboglu H, Budak F, Kasap M, Gacar G, Torol S, Karadenizli A et al. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. J Antimicrob Chemother 2006;58:537–542.
   PubMed Web of Science ®Google Scholar
• Walther-Rasmussen J, Høiby N. OXA-type carbapenemases. J Antimicrob Chemother 2006;57:373–383.
   PubMed Web of Science ®Google Scholar
• Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004;48:15–22.
   PubMed Web of Science ®Google Scholar
• Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother 2008;52:2950–2954.
   PubMed Web of Science ®Google Scholar
• Carrër A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 2010;54:1369–1373.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. Wayne, Pennsylvania, USA; 2003.
   Google Scholar
• Meric M, Kasap M, Gacar G, Budak F, Dundar D, Kolayli F et al. Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Turkey. FEMS Microbiol Lett 2008;282:214–218.
   PubMed Web of Science ®Google Scholar
• Gacar GG, Midilli K, Kolayli F, Ergen K, Gundes S, Hosoglu S et al. Genetic and enzymatic properties of metallo-beta-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae. Antimicrob Agents Chemother 2005;49:4400–4403.
   PubMed Web of Science ®Google Scholar
• Docquier JD, Calderone V, De Luca F, Benvenuti M, Giuliani F, Bellucci L et al. Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases. Chem Biol 2009;16:540–547.
   PubMed Web of Science ®Google Scholar
• Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res 2005;33:W363–W367.
   PubMed Web of Science ®Google Scholar
• Duhovny D, Nussinov R, Wolfson HJ. Efficient unbound docking of rigid molecules. In Gusfield et al., Ed. Proceedings of the 2′nd Workshop on Algorithms in Bioinformatics(WABI), Lecture Notes in Computer Science 2452. Rome, Italy: Springer Verlag, 2002. pp 185–200.
   Google Scholar
• Bou G, Oliver A, Martínez-Beltrán J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother 2000;44:1556–1561.
   PubMed Web of Science ®Google Scholar
• Santillana E, Beceiro A, Bou G, Romero A. Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis. Proc Natl Acad Sci USA 2007;104:5354–5359.
   PubMed Web of Science ®Google Scholar
• Ledent P, Raquet X, Joris B, Van Beeumen J, Frère JM. A comparative study of class-D beta-lactamases. Biochem J 1993;292 (Pt 2):555–562.
   PubMed Web of Science ®Google Scholar
• Naas T, Nordmann P. OXA-type beta-lactamases. Curr Pharm Des 1999;5:865–879.
   PubMed Web of Science ®Google Scholar
• Couture F, Lachapelle J, Levesque RC. Phylogeny of LCR-1 and OXA-5 with class A and class D beta-lactamases. Mol Microbiol 1992;6:1693–1705.
   PubMed Web of Science ®Google Scholar